Calgary Flames assistant GM Chris Snow, former Star Tribune writer, diagnosed with ALS

Chris Snow, an assistant general manager for the Calgary Flames who started his hockey career as the Wild beat writer for the Star Tribune, has been diagnosed with ALS.

Snow's wife, Kelsie, posted a letter on NHL.com detailing the diagnosis and treatment. ALS claimed the lives of Snow's father and two paternal uncles, she wrote.

Chris Snow, 38, covered the Wild for the Star Tribune in 2003-04 before taking the Red Sox beat at the Boston Globe. In 2006, he left journalism to become the Wild's director of hockey operations under General Manager Doug Risebrough, a role he filled until 2010. He joined the Flames working as a scout and in analytics and was promoted to assistant GM earlier this year.

Kelsie Smith Snow is a former sportswriter who covered the Twins for the St. Paul Pioneer Press. The Snows have two young children. (photo courtesy Calgary Flames)

Here is the text of Kelsie Snow's posting on the Flames website:

Dear Hockey Family,

I'm here to share news we prayed so hard we'd never have.

ALS is a horrible disease, and when we went to Miami to see one of the best ALS doctors and researchers out there, we prayed hard. We believe there are miracles in the world and maybe, maybe we would get one.

And we did, just not the one we'd hoped for.

In the same breath as the doctor telling us that Chris was in the early stages of ALS, he also gave us hope. The next step, he said, was to enroll Chris in a clinical trial for the most encouraging ALS gene therapy treatment to come along. The drug targets a specific genetic mutation that has devastated Chris' family. Just over one year ago Chris' dad passed away from ALS. We have also lost both of Chris' paternal uncles and his 28-year-old cousin to this disease.

In the simplest terms, this drug works by silencing the effects of the mutated gene, and in Miami we could see how hopeful the doctor felt. So hopeful that when I asked if he believes this drug could stop progression entirely, he said, "We don't know, but it's not outside the realm of possibility."

And so we are leaning into that possibility, as hard as we can, working to stay positive and living with intention every single day. And now we believe we have results to lean into as well.

Someone has to be the first person to live with ALS rather than die from it, and one thing I've always known about Chris is that he finds a way. No matter the obstacle, no matter how unprecedented the situation may be - he always, always finds a way.

We know that our hockey family will want to help, and we appreciate that so much. Here's how you can do that.

Be positive and hopeful with us, pray for us in whatever way you pray, and don't treat us - most especially Chris - differently than you always have. He is the same person today he was yesterday and he will be the same person tomorrow and in two months and beyond. Hug your family, wring all the joy from each moment of your life, play with your children, and be present - all things at which Chris has always been wonderful.

Continue to love us and love our kids. Of all the devastation this diagnosis brought, the idea of telling the two of them they were going to lose their dad was the most crushing. But now we have hope and, we believe, a different story.

The most tangible way you can help us is by donating to research. ALS is a rare disease, and rare diseases aren't easily cured. Fewer than 20,000 people in North America are estimated to be living with ALS. Of them only 2,000 are living with familial ALS, the kind caused by a gene passed down within a family. And yet this has torn through Chris' family. At the University of Miami researchers are focused on developing treatments for ALS, including those with familial forms of the disease. They have pioneered the study of the pre-symptomatic stage of ALS with the goal of one day being able to delay or even prevent the disease. With your help they can afford to do more and do it faster. To donate, please visit this link: http://uom.convio.net/goto/chrissnow

As our neurologist said after Chris received his first dose in the trial - "We're here to make history."